Dr. George M. Cherian
Formosa HMT Biotech, established and registered in 2016, has developed a low-cost, affordable, patented process for the manufacture of high capacity Zinc hypoMTTM Metallothionein (“hypoMTs”) that supplements and boosts the body’s ability to defend against and reverse damage caused by oxidative stress.
Chief Scientist for Formosa, Dr. George M. Cherian, a Professor Emeritus in the Department of Pathology and Laboratory Medicine, has been a part of the Formosa HMT Biotech company since its infancy.
Dr. Cherian is a distinguished metal toxicologist with over 40 years of experience conducting research in developmental biology and cancer research, has received various honours throughout his career and has served on review committees for various research grants.
